| Brand Name | BIPOLAR HIP |
| Common Device Name | SHELL, BIPOLAR, MODULAR, ENCORE, SIZE46 |
| Manufacturer (Section D) |
| ENCORE MEDICAL L.P. |
| 9800 metric blvd |
| austin, tx 78758-5445 |
|
| Manufacturer (Section G) |
| ENCORE MEDICAL L.P. |
| 9800 metric blvd |
|
| austin, tx 78758-5445 |
|
| Manufacturer Contact |
|
james
mcmohan
|
| 9800 metric blvd |
| austin, tx 78758-5445
|
|
| MDR Report Key | 14690236 |
| Report Number | 1644408-2022-00777 |
| Device Sequence Number | 12456940 |
| Product Code |
KWY
|
| UDI-Device Identifier | 00888912077378 |
| UDI-Public | (01)00888912077378 |
| Combination Product (Y/N) | N |
| PMA/510(K) Number | K953510 |
| Number of Events Summarized | 1 |
| Summary Report (Y/N) | N |
| Device Implanted Year | 2022 |
| Device Explanted Year | 2022 |
| Serviced by Third Party (Y/N) | N |
| Reporter Type |
Manufacturer
|
| Report Source |
Company Representative |
| Initial Reporter Occupation |
Non-Healthcare Professional
|
| Type of Report
| Initial |
| Report Date (Section B) |
06/13/2022 |
| 1 Device was Involved in the Event |
|
| 1 Patient was Involved in the Event |
|
| Is this an Adverse Event Report? |
Yes
|
| Is this a Product Problem Report? |
No
|
| Operator of Device |
Health Professional
|
| Device Expiration Date | 05/26/2026 |
| Device Model Number | 412-02-046 |
| Device Catalogue Number | 412-02-046 |
| Device Lot Number | 991B1201 |
| Was Device Available for Evaluation? |
No
|
| Type of Report(Section G) | Thirty-Day |
| Initial Date Received by Manufacturer | 06/01/2022 |
| Initial Report FDA Received Date | 06/14/2022 |
| Was Device Evaluated by Manufacturer? (Y/N) |
Device Not Returned to Manufacturer
|
| Date Device Manufactured | 06/04/2021 |
| Is the Device Labeled for Single Use? (Y/N) |
Yes
|
Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N) |
No
|
| Usage of Device |
Initial
|
| Patient Sequence Number | 1 |
Concomitant Medical Products and Therapy/Usage Dates | 425-01-009, LOT 062C1312.; 497-28-000, LOT 629C1678. |
| Outcome Attributed to Adverse Event |
Required Intervention;
|
| Patient Age | 64 YR |
| Patient Sex | Female |
|
|